Dr. Christopher Steevens, MD

Dr. Steevens practices at Ummc Maple Grove Cancer Infusion - Infusion Therapy - HOPD in Maple Grove, Minnesota.

Dr. Steevens' NPI, 1992094064, was assigned on March 29, 2011. Dr. Steevens graduated from University of Minnesota Medical School in 2011. Dr. Steevens holds Minnesota license 63499.

Dr. Steevens' primary practice is Ummc Maple Grove Cancer Infusion - Infusion Therapy - HOPD, at 14500 99th Ave N, Maple Grove, MN 55369.

Dr. Steevens' primary practice is Ummc Maple Grove Cancer Infusion - Infusion Therapy - HOPD in Maple Grove, Minnesota. Dr. Steevens is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Steevens to 9 more medical groups, 4 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steevens practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Steevens' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Steevens is licensed in Minnesota.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis and upper GI endoscopy among the conditions Dr. Steevens treats.

CMS data shows 355 Medicare services from Dr. Steevens across 10 procedure codes in 2024, for 198 Medicare patients. Medicare paid $27,302 for them.

CMS counts 198 Medicare patients who saw Dr. Steevens in 2024. The largest group is 65 to 74, with 111 patients. 65% of them have high blood pressure, and 59% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Steevens' median patient age at 57, with 54% women.

In 2024, Dr. Steevens wrote 448 Medicare Part D claims for 210 patients. 69% of them were for generic drugs. CMS names the drug for 301 of them, across 12 drugs with 11 or more claims each, at $273,155 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Steevens for performance year 2024, reported as part of a group. Dr. Steevens accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Steevens as offering telehealth. CMS counts 101 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Steevens, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Steevens, published from 2012 to 2018. Dr. Steevens' most frequent co-authors are Maisa Ismail Abdalla, MD, James Abraham, MD and Sandeep Bahadur, MD.

Dr. Steevens graduated from University of Minnesota Medical School in 2011.

Dr. Steevens is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.